BROADWATER CAPITAL MANAGEMENT LLC

Position in ABBV — AbbVie Inc.

CIK 2084339 BOSTON, MA

Position in ABBV

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$3,260,499

+$398,984 QoQ

Shares Held

12,957

-1.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.54%

of 13F equity value

Holder Rank

#1,592

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

BROADWATER CAPITAL MANAGEMENT LLC holds $13,165,231 across 9 Drug Manufacturers - General names. ABBV ranks #3 (24.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	21,130	$5,366,386
2	MRK	Merck & Co., Inc.	29,582	$3,801,287
3	ABBV	AbbVie Inc. This page	12,957	$3,260,499
4	BMY	Bristol Myers Squibb Co	6,545	$377,122
5	PFE	Pfizer Inc	10,117	$243,617
6	NVS	Novartis AG	370	$57,986
7	BIIB	Biogen Inc.	100	$21,606
8	AMGN	Amgen Inc	58	$21,002

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,260,499	12,957	-1.5%	Shares	Sole	2026-07-24
2026-03-31	$2,861,515	13,157	0.0%	Shares	Sole	2026-07-24
2025-12-31	$3,006,242	13,157	-0.2%	Shares	Sole	2026-02-03
2025-09-30	$3,052,160	13,182	-0.3%	Shares	Sole	2026-02-03
2025-06-30	$2,453,339	13,217	-2.0%	Shares	Sole	2026-02-03
2025-03-31	$2,824,539	13,481	-0.2%	Shares	Sole	2026-02-03
2024-12-31	$2,400,727	13,510	-1.2%	Shares	Sole	2026-02-03
2024-09-30	$2,699,354	13,669	+0.0%	Shares	Sole	2026-02-03
2024-06-30	$2,344,335	13,668	+0.0%	Shares	Sole	2026-02-03
2024-03-31	$2,488,760	13,667	-2.1%	Shares	Sole	2026-02-03
2023-12-31	$2,164,465	13,967	—	Shares	Sole	2026-02-03
No filing history on record for this holder in this stock.